In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Innocoll Holdings Limited

https://www.innocoll.com/

Latest From Innocoll Holdings Limited

Finance Watch: Days Of Reckoning As Biopharma Valuations, Fundraising Opportunities Fluctuate

Biotech stock indices have seen a recent recovery but remain well below their 2021 peaks raising questions about the likelihood of raising money for R&D. The number of companies announcing leadership changes, shifting pipeline priorities and job cuts is rising as a result.

Financing Leadership

Deal Watch: Roche, Pfizer, GSK Close Out 2021 With Licensing Transactions

Ahead of the usual flurry of deal-making in January, Roche gets retinal cell therapy candidate from Lineage Cell Therapeutics, Pfizer subsidiary Amplyx licenses antiviral candidate to Vera, and GSK expands neurology tie-up with Ligand.

Deal Watch Business Strategies

Keeping Track: Gavreto, Sogroya Bring Annual CDER Novel Approvals To 40; New Analgesic Products Make It Past US FDA

The latest drug approval news and highlights from the Pink Sheet’s US FDA Performance Tracker.

US FDA Performance Tracker Approvals

August User Fee Calendar Features Gene Therapy, Analgesics, And Of Course Oncology

Sixteen applications are in line for US FDA decisions in August. Ten are novel agents.

US FDA Performance Tracker Drug Review
See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
    • Drug Delivery
    • Specialty Pharmaceuticals
    • Drug Delivery
      • Site Specific
      • Topical Delivery
  • Medical Devices
    • Biomaterials
    • Implantable Devices
  • Other Names / Subsidiaries
    • Gurnet Point L.P.
    • Innocoll Pharmaceuticals Limited
    • Innocoll Inc
    • Innocoll Biotherapeutics plc
UsernamePublicRestriction

Register